Home
Search:
1146 feeds
357 categories
10322 articles (<24 hours)
104 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

Science


Valid HTML 4.01 Transitional

RSS FeedsPureTech´s Microbiome Programme Advances into a Phase 1a/1b Clinical Trial
(World News Science)

 
 

7 december 2017 12:40:46

 
PureTech´s Microbiome Programme Advances into a Phase 1a/1b Clinical Trial
(World News Science)
 




VE303 is first known rationally-defined bacterial consortium in powder form to enter the clinic and has received Orphan Drug Designation from the US FDA for C. difficile indication PureTech Health plc (LSE: PRTC), an advanced, clinical-stage biopharmaceutical company, is pleased to note that Vedanta Biosciences, an affiliate of PureTech Health, today announced the initiation of a Phase 1a/1b clinical trial of VE303, the Company`s lead, orally-administered, human microbiome-derived product candidate. VE303 is the first known investigational drug consisting of rationally-defined bacterial consortium in powder form to enter the clinic. It is comprised of a group of bacteria selected based on...
 
5 viewsCategory: Science
 
ScottishPower makes fuel go further with Trakm8 telematics
(World News Science)
Life under the surface in live broadcast
(World News Science)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2017 Indigonet Services B.V.. Contact: Tim Hulsen
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Travel Photos Nachrichten Indigonet Finances Leer Mandarijn
Indigonet Services BV is not responsible for any incorrect or outdated information on this site.
If, however, you would like to see an article removed, you can send us an e-mail quoting the article number.